Maciej M. Mrugala MD, PhD, MPH, FAAN

Dr. Maciej M. Mrugala, MD, PhD, is a distinguished neuro-oncologist and physician-scientist specializing in the diagnosis, treatment, and research of primary and metastatic brain tumors. He serves as a member of the Brain Tumor Program at the Arizona campus of the Mayo Clinic, where he provides multidisciplinary care for patients with complex neurological cancers while advancing innovative therapeutic approaches.

Dr. Mrugala earned both his medical degree and doctorate and has built an internationally recognized career in neuro-oncology. His clinical and research interests focus on glioblastoma, tumor-treating fields, molecular diagnostics, precision medicine, and emerging therapies for central nervous system tumors. He has contributed extensively to the scientific literature, authoring influential publications on glioblastoma management, neuro-oncologic practice, molecular testing, and the global state of neuro-oncology care.

Throughout his career, Dr. Mrugala has collaborated with leading academic and cancer research institutions, including the University of Washington, Fred Hutchinson Cancer Research Center, and Mayo Clinic. His work has helped advance understanding of brain tumor biology, treatment outcomes, and patient-centered approaches to neuro-oncology care.

In addition to his clinical responsibilities, Dr. Mrugala is actively involved in clinical research, education, and international professional initiatives aimed at improving outcomes and quality of life for patients with brain tumors. His contributions continue to shape the evolving field of neuro-oncology through innovation, collaboration, and a commitment to translating scientific discoveries into meaningful patient care.